a company, which engages in the development and commercialization of treatments for dermatological diseases.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EATVX | 44.07 | 0.44 | +1.01% |
Eaton Vance Tx-Mgd Value A | |||
EAFVX | 22.19 | 0.22 | +1.00% |
Eaton Vance Focused Value Opps A | |||
PRKZX | 8.08 | 0.05 | +0.62% |
PGIM Real Estate Income Z | |||
MLACX | 6.40 | 0.02 | +0.31% |
NYLI Winslow Large Cap Growth Class C | |||
PIEIX | 26.09 | -0.10 | -0.38% |
Principal Glb Emerging Markets Inst |
A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with BEAM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To ARQT | 1D Price Change % | ||
---|---|---|---|---|
ARQT | 100% | +0.89% | ||
BEAM - ARQT | 39% Loosely correlated | -3.16% | ||
ARWR - ARQT | 37% Loosely correlated | +0.59% | ||
PLRX - ARQT | 37% Loosely correlated | -0.47% | ||
SANA - ARQT | 36% Loosely correlated | +7.20% | ||
RXRX - ARQT | 36% Loosely correlated | -3.67% | ||
More |